Sofia, Bulgaria, August 28, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 27, 2025 the Company sold 43 600 (forty-three thousand and six hundred) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 108 248.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.48.

Sofia, Bulgaria, August 27, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 26, 2025 the Company sold 49 801 (forty-nine thousand eight hundred and one) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 123 510.05 on the Bulgarian Stock Exchange, the average price per share was BGN 2.48.

Sofia, Bulgaria, August 26, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 25, 2025 the Company sold 303 540 (three hundred three thousand five hundred and forty) treasury shares representing 0.06% of the share capital of the Company, at a total value of BGN 747 218.50 on the Bulgarian Stock Exchange, the average price per share was BGN 2.46.

Sofia, Bulgaria, August 25, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 22, 2025 the Company sold 99 775 (ninety-nine thousand seven hundred and seventy-five) treasury shares representing 0.02% of the share capital of the Company, at a total value of BGN 244 852.50 on the Bulgarian Stock Exchange, the average price per share was BGN 2.45.

Sofia, Bulgaria, August 22, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 21, 2025 the Company sold 17 126 (seventeen thousand one hundred and twenty-six) treasury shares representing 0.003% of the share capital of the Company, at a total value of BGN 41 961.96 on the Bulgarian Stock Exchange, the average price per share was BGN 2.45.

Sofia, Bulgaria, August 21, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 20, 2025 the Company sold 68 049 (sixty-eight thousand and forty-nine) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 166 787.20 on the Bulgarian Stock Exchange, the average price per share was BGN 2.45.

Sofia, Bulgaria, August 20, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for July 2025 the Company recorded decrease in sales of 23% compared to the same month of the previous year, incl. 25% decrease in domestic sales and 22% decrease in export sales.

For the period from the beginning of 2025, the Company realized a 4% increase in sales, including 6% decrease in domestic sales and a 12% increase in export sales.